Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda operates in various business sectors.
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA) - Net Assets
Latest net assets as of : EGP- EGP
Based on the latest financial reports, Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA) has net assets worth EGP- EGP as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (EGP-) and total liabilities (EGP-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | EGP- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda - Net Assets Trend (None–None)
This chart illustrates how Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (None–None)
The table below shows the annual net assets of Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda Competitors by Market Cap
The table below lists competitors of Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brasnova Energy Materials Inc.
V:BEM
|
$811.54 |
|
Teuza A Fairchild Technology Venture Ltd
TA:TUZA
|
$811.85 |
|
GLOBAL GEOSCIEN
BE:4G1
|
$812.93 |
|
Nasr Company for Civil Works
EGX:NCCW
|
$814.31 |
|
Epazz Inc
PINK:EPAZ
|
$810.53 |
|
Emperor Metals Inc.
OTCQB:EMAUF
|
$809.63 |
|
Troy Minerals Inc.
OTCQB:TROYF
|
$808.97 |
|
Apna Microfinance Bank Ltd
KAR:AMBL
|
$807.92 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.